Burn, Edward http://orcid.org/0000-0002-9286-1128
You, Seng Chan http://orcid.org/0000-0002-5052-6399
Sena, Anthony G.
Kostka, Kristin http://orcid.org/0000-0003-2595-8736
Abedtash, Hamed http://orcid.org/0000-0002-9139-5452
Abrahão, Maria Tereza F. http://orcid.org/0000-0003-2701-670X
Alberga, Amanda
Alghoul, Heba http://orcid.org/0000-0001-8234-5843
Alser, Osaid http://orcid.org/0000-0001-6743-803X
Alshammari, Thamir M.
Aragon, Maria
Areia, Carlos http://orcid.org/0000-0002-4668-7069
Banda, Juan M. http://orcid.org/0000-0001-8499-824X
Cho, Jaehyeong
Culhane, Aedin C. http://orcid.org/0000-0002-1395-9734
Davydov, Alexander
DeFalco, Frank J.
Duarte-Salles, Talita
DuVall, Scott
Falconer, Thomas
Fernandez-Bertolin, Sergio
Gao, Weihua
Golozar, Asieh http://orcid.org/0000-0002-4243-155X
Hardin, Jill
Hripcsak, George
Huser, Vojtech
Jeon, Hokyun http://orcid.org/0000-0002-6220-4207
Jing, Yonghua
Jung, Chi Young
Kaas-Hansen, Benjamin Skov http://orcid.org/0000-0003-1023-0371
Kaduk, Denys
Kent, Seamus
Kim, Yeesuk http://orcid.org/0000-0003-4956-0693
Kolovos, Spyros
Lane, Jennifer C. E. http://orcid.org/0000-0002-1729-8654
Lee, Hyejin
Lynch, Kristine E.
Makadia, Rupa
Matheny, Michael E.
Mehta, Paras P. http://orcid.org/0000-0002-0233-9871
Morales, Daniel R.
Natarajan, Karthik http://orcid.org/0000-0002-9066-9431
Nyberg, Fredrik http://orcid.org/0000-0003-0892-5668
Ostropolets, Anna
Park, Rae Woong
Park, Jimyung http://orcid.org/0000-0002-6998-2546
Posada, Jose D. http://orcid.org/0000-0003-3864-0241
Prats-Uribe, Albert http://orcid.org/0000-0003-1202-9153
Rao, Gowtham
Reich, Christian
Rho, Yeunsook
Rijnbeek, Peter
Schilling, Lisa M.
Schuemie, Martijn
Shah, Nigam H. http://orcid.org/0000-0001-9385-7158
Shoaibi, Azza
Song, Seokyoung http://orcid.org/0000-0002-5653-7005
Spotnitz, Matthew
Suchard, Marc A. http://orcid.org/0000-0001-9818-479X
Swerdel, Joel N.
Vizcaya, David http://orcid.org/0000-0003-0248-7636
Volpe, Salvatore
Wen, Haini
Williams, Andrew E. http://orcid.org/0000-0002-0692-412X
Yimer, Belay B. http://orcid.org/0000-0001-8621-6539
Zhang, Lin http://orcid.org/0000-0002-2064-8440
Zhuk, Oleg
Prieto-Alhambra, Daniel http://orcid.org/0000-0002-3950-6346
Ryan, Patrick
Funding for this research was provided by:
Innovative Medicines Initiative (806968)
Article History
Received: 1 July 2020
Accepted: 10 September 2020
First Online: 6 October 2020
Competing interests
: All authors have completed the ICMJE uniform disclosure form, with the following declarations made: D.P.A. reports grants and other from AMGEN, grants, non-financial support and other from UCB Biopharma, grants from Les Laboratoires Servier, outside the submitted work; and Janssen, on behalf of IMI-funded EHDEN and EMIF consortiums, and Synapse Management Partners have supported training programmes organised by DPA’s department and open for external participants. D.V. reports personal fees from Bayer, outside the submitted work, and he is a full-time employee at a pharmaceutical company. DM reports funding support from the Wellcome Trust, NIHR, Scottish CSO and Tenovus Scotland for research unrelated to this work. S.C.Y. reports grants from Korean Ministry of Health & Welfare, grants from Korean Ministry of Trade, Industry & Energy, during the conduct of the study. A.G. reports personal fees from Regeneron Pharmaceuticals, outside the submitted work, and she a full-time employee at Regeneron Pharmaceuticals. This work was not conducted at Regeneron Pharmaceuticals. Y.J. reports employee of AbbVie and owns company stock. A.A. reports that he is currently employed at Alberta Health Services (AHS) as a Data Science Lead redeployed as an epidemiologist to aid in the COVID-19 response. This work was not conducted at AHS, within AHS working hours, or with AHS staff. He contributed and conducted this work as an Independent Epidemiologist, as a member of the Observational Health Data Sciences and Informatics (OHDSI) Network. P.R. reports grants from Innovative Medicines Initiative, grants from Janssen Research and Development, during the conduct of the study. M.S. reports grants from US National Science Foundation, grants from US National Institutes of Health, grants from IQVIA, personal fees from Janssen Research and Development, during the conduct of the study. G.H. reports grants from US NIH National Library of Medicine, during the conduct of the study; grants from Janssen Research, outside the submitted work. A.P.U. reports grants from Fundacion Alfonso Martin Escudero, grants from Medical Research Council, outside the submitted work. H.A. reports personal fees from Eli Lilly and Company, outside the submitted work. A.S. reports personal fees from Janssen Research & Development, during the conduct of the study; personal fees from Janssen Research & Development, outside the submitted work. A.S. is a full-time employee of Janssen and shareholder of Johnson & Johnson. G.R. is a full-time employee of Janssen and shareholder of Johnson & Johnson. F.D. reports personal fees from Janssen Research & Development, during the conduct of the study; personal fees from Janssen Research & Development, outside the submitted work. R.W.P. reports grants from Korean Ministry of Health & Welfare, grants from Korean Ministry of Trade, Industry & Energy, during the conduct of the study. J.P. reports grants from Korean Ministry of Health & Welfare, grants from Korean Ministry of Trade, Industry & Energy, during the conduct of the study. J.C. reports grants from Korean Ministry of Health & Welfare, grants from Korean Ministry of Trade, Industry & Energy, during the conduct of the study. S.D. reports grants from Anolinx, LLC, grants from Astellas Pharma, Inc, grants from AstraZeneca Pharmaceuticals LP, grants from Boehringer Ingelheim International GmbH, grants from Celgene Corporation, grants from Eli Lilly and Company, grants from Genentech Inc., grants from Genomic Health, Inc., grants from Gilead Sciences Inc., grants from GlaxoSmithKline PLC, grants from Innocrin Pharmaceuticals Inc., grants from Janssen Pharmaceuticals, Inc., grants from Kantar Health, grants from Myriad Genetic Laboratories, Inc., grants from Novartis International AG, grants from Parexel International Corporation through the University of Utah or Western Institute for Biomedical Research outside the submitted work. H.J. reports grants from Korean Ministry of Health & Welfare, grants from Korean Ministry of Trade, Industry & Energy, during the conduct of the study. B.S.K.H. reports grants from Innovation Fund Denmark (5153-00002B) and the Novo Nordisk Foundation (NNF14CC0001), outside the submitted work. K.K. reports she is an employee of IQVIA. CR reports he is an employee of IQVIA. J.S. reports other from Janssen R&D, during the conduct of the study; other from Janssen R&D, outside the submitted work; and J.S. was a full-time employee of Johnson & Johnson, or a subsidiary, at the time the study was conducted. J.S. owns stock, stock options, and pension rights from the company. R.M. reports and is an employee of Janssen Research and Development. W.G. is an AbbVie employee. P.R. reports and is an employee of Janssen Research and Development and shareholder of Johnson & Johnson. M.S. is a full-time employee of Janssen R&D, and a shareholder of Johnson & Johnson. J.H. reports other from Janssen Research & Development, during the conduct of the study; other from Janssen Research & Development, outside the submitted work; and full-time employee of Janssen and shareholder of Johnson & Johnson. All other authors declare no competing interests.